HFA-PEFF score as an independent predictor of 2-year mortality in liver cirrhosis patients

被引:3
|
作者
Dimitroglou, Yannis [1 ,3 ]
Tsartsalis, Dimitrios [1 ]
Vasilieva, Larisa [2 ]
Patsourakos, Dimitrios [1 ]
Kalompatsou, Argyro [1 ]
Alexopoulou, Alexandra [2 ]
Tousoulis, Dimitris [1 ]
Tsioufis, Konstantinos [1 ]
Aggeli, Constantina [1 ]
机构
[1] Natl & Kapodistrian Univ Athens, Hippokrat Gen Hosp, Med Sch, Dept Cardiol 1, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Hippokrat Gen Hosp, Med Sch, Dept Internal Med 2, Athens, Greece
[3] Gen Hosp Athens Hippokrat, Dept Cardiol 1, Vasilissis Sophias 114, Athens 11527, Greece
关键词
cirrhotic cardiomyopathy; diastolic dysfunction; echocardiography; HFpEF; liver cirrhosis; natriuretic peptides; AMERICAN SOCIETY; DIASTOLIC DYSFUNCTION; EUROPEAN ASSOCIATION; ECHOCARDIOGRAPHY; RECOMMENDATIONS; CARDIOMYOPATHY; SURVIVAL; DISEASE; UPDATE; MODEL;
D O I
10.1097/MEG.0000000000002472
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and aimsCardiovascular complications of liver cirrhosis include high cardiac output heart failure with reduced afterload and diastolic dysfunction. Heart Failure Association Pre-test assessment, Echocardiography and natriuretic peptide, Functional testing, Final etiology (HFA-PEFF) (values 0-6) is a diagnostic tool for heart failure. It is a cluster of echocardiographic and biochemical parameters. The purpose of this prospective study was to assess if HFA-PEFF score is associated with the severity of liver disease and to determine its prognostic significance in patients with cirrhosis. MethodsPatients with cirrhosis without an acute event were enrolled. A comprehensive echocardiography study was conducted, brain natriuretic peptide and N-terminal-pro-B-type Natriuretic Peptide levels were measured and HFA-PEFF score was calculated. All patients were prospectively followed up after enrollment. The study end-point was defined as the composite of all-cause death. ResultsSeventy-two consecutive patients [median age 59 years (inter-quartile range: 52-65), 72.2% males, Model for End-stage Liver Disease (MELD) 12.9 (8.5-16.3)] were included. The 52.8% had a high HFA-PEFF score (5 or 6) and the 47.2% intermediate/low score (0-4). HFA-PEFF score was correlated with MELD score (rho = 0.566, P < 0.001), but not with age, SBP and heart rate. The median follow-up was 24.2 (9.5-38.8) months. The 1- and 2-year cumulative mortality was higher in patients with high HFA-PEFF compared to those with intermediate/low (log-rank P < 0.001 for both). The predicted 2-year probability of survival in high vs intermediate/low HFA-PEFF was found to be a prognostic factor of death even when adjusted for age, gender and MELD score [hazard ratio = 3.539 (1.134-11.046), P = 0.029]. ConclusionHFA-PEFF score is high among patients with liver cirrhosis, especially those with advanced liver disease. HFA-PEFF score is associated with survival even when adjusting for cirrhosis severity.
引用
下载
收藏
页码:204 / 211
页数:8
相关论文
共 50 条
  • [41] Hepatic Hydrothorax: An Independent Predictor of Mortality in Cirrhosis? Is the MELD-Na Score Worth Its Salt?
    Asotibe, Jennifer C.
    Banini, Bubu A.
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (10) : 4609 - 4611
  • [42] A 2-YEAR TRIAL OF ELECTIVE ENDOSCOPIC SCLEROTHERAPY IN PATIENTS WITH LIVER-CIRRHOSIS AND BLEEDING VARICES
    BRETAGNE, JF
    MORISOT, D
    GASTARD, J
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1985, 9 (11): : 809 - 813
  • [43] Validation of the HFA-PEFF and the H2FPEF scores for the diagnosis of heart failure with preserved ejection fraction in Japanese patients:a report from the Japanese multicentre registry
    Tada, A.
    Nagai, T.
    Omote, K.
    Tsujinaga, S.
    Kamiya, K.
    Konishi, T.
    Sato, T.
    Komoriyama, H.
    Kobayashi, Y.
    Takenaka, S.
    Mizuguchi, Y.
    Yamamoto, K.
    Yoshikawa, T.
    Saito, Y.
    Anzai, T.
    EUROPEAN HEART JOURNAL, 2021, 42 : 731 - 731
  • [44] Apache II score at time of infection as an independent predictor of mortality in trauma patients
    Weed, AC
    Raymond, DP
    Claridge, JA
    Oh, CK
    Young, JS
    Sawyer, RG
    CRITICAL CARE MEDICINE, 2001, 29 (12) : A178 - A178
  • [45] Religious struggle as a predictor of mortality among medically ill elderly patients -: A 2-year longitudinal study
    Pargament, KI
    Koenig, HG
    Tarakeshwar, N
    Hahn, J
    ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (15) : 1881 - 1885
  • [46] Exercise Capacity Is the Most Powerful Predictor of 2-Year Mortality in Patients with Left Ventricular Systolic Dysfunction
    Reibis, Rona
    Treszl, Andras
    Wegscheider, Karl
    Ehrlich, Bettina
    Dissmann, Ruediger
    Voeller, Heinz
    HERZ, 2010, 35 (02) : 104 - 110
  • [47] Hyponatremia a valuable predictor of early mortality in patients with cirrhosis listed for liver transplantation
    Moini, Maryam
    Hoseini-Asl, Mohammad Kazem
    Taghavi, Seyed Alireza
    Sagheb, Mohammad M.
    Nikeghbalian, Saman
    Salahi, Heshmatalah
    Bahador, Ali
    Motazedian, Motahareh
    Jafari, Peyman
    Malek-Hosseini, Sayed Ali
    CLINICAL TRANSPLANTATION, 2011, 25 (04) : 638 - 645
  • [48] Lactate but not hemoglobin is a predictor for mortality in patients with liver cirrhosis and upper GI bleeding
    Horvatits, Thomas
    Seiz, Oliver
    Reher, Dominik
    Drolz, Andreas
    Groth, Stefan
    Roesch, Thomas
    Lohse, Ansgar
    Kluwe, Johannes
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E648 - E648
  • [49] LOW SUBCUTANEOUS ADIPOSE TISSUE INDEX IS AN INDEPENDENT PREDICTOR OF MORTALITY IN FEMALE PATIENTS WITH CIRRHOSIS
    Abow-Mohamed, Ikram
    Alabdulkarim, Balqis
    Zhao, Xun
    Kablawi, Dana
    Desgagne, Estelle
    Deschenes, Marc
    Wong, Philip
    Chen, Tianyan
    Sebastiani, Giada
    Rehany, Benjamin
    Abu-Nada, Mohamed
    Valenti, David
    Bessissow, Ali
    Benmassaoud, Amine
    HEPATOLOGY, 2023, 78 : S1397 - S1398
  • [50] The relationship of systemic and pulmonary arterial parameters with HFpEF scores (H2FPEF, HFA-PEFF) and diastolic dysfunction parameters in heart failure patients with preserved ejection fraction
    Yavuz, Yunus Emre
    Soylu, Ahmet
    Gurbuz, Ahmet Seyfettin
    JOURNAL OF CLINICAL ULTRASOUND, 2024, 52 (01) : 39 - 50